ClinConnect ClinConnect Logo
Search / Trial NCT02173847

Laser Assisted Procedures in Penetrating Keratoplasty

Launched by OSPEDALE SANTO STEFANO · Jun 23, 2014

Trial Information

Current as of July 09, 2025

Completed

Keywords

Anvil Shaped Corneal Graft Penetrating Keratoplasty Femtosecond Laser Laser Welding

ClinConnect Summary

The femtosecond laser is used to cut an anvil-shaped laser incision used in PK. This design has the purpose to create a more structurally stable and predictable wound configuration with the aim of a faster recovery of vision and higher optical quality, compared with the conventional blade trephination and the most common laser-cut patterns. The "anvil" profile is designed as described in the followings. Donor and recipient corneal trephination are performed using a 150 kHz FS laser (iFS150TM, IntralaseTM FS Laser, Abbott Medical Optics -AMO, Santa Ana, CA, USA). As concerned iFS150 settings...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Corneal dystrophy
  • keratoconus in its final stages
  • post-herpetic leukoma
  • corneal scar
  • Exclusion Criteria:
  • systemic diseases
  • previous corneal surgery
  • glaucoma

About Ospedale Santo Stefano

Ospedale Santo Stefano is a renowned healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care, the hospital leverages its multidisciplinary team of experienced clinicians and researchers to conduct rigorous studies across various therapeutic areas. Ospedale Santo Stefano aims to contribute to the scientific community by fostering collaboration and adhering to the highest ethical standards, ensuring that all research initiatives prioritize patient safety and well-being. Through its clinical trial programs, the hospital seeks to translate cutting-edge research into practical treatments that enhance the quality of life for patients.

Locations

Prato, , Italy

Patients applied

0 patients applied

Trial Officials

Luca Menabuoni, MD

Principal Investigator

Head of Corneal and Experimental Surgery at the Department of Ophthalmology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials